Indiana Health Industry Forum (IHIF) Cancer Oncology Summit
December 1-2, 2008
Thank you for joining us for the third annual topic summit in our conference series examining important, translational, health and life science research strengths for Indiana. Following on summits organized around orthopedics and diabetes, this year's conference examined the work being done in Indiana, from bench to bedside, around cancer and cancer treatment.
The conference brought together a broad range of Indiana institutions, companies, and individuals with a common interest in cancer research, diagnosis and treatment. The event provided a combination of presentations, panel discussions, and networking opportunities.
* Follow-up Discussion - please share your thoughts and comments and help us determine the next steps in Indiana's cancer conversation
* Panel Presentations - available presentations are posted below
December 1
Keynote Presentation: Eric K. Rowinsky, M.D., Chief Medical Officer, Executive Vice President, ImClone Systems, Inc.
December 2
Basic Science
Moderator: Daniel Raftery, Ph.D., Professor of Analytical Chemistry, Purdue University; Founder MatrixBio;
Panelists:
* Linda Malkas, Ph.D., Professor of Medicine, Vera Bradley Chair for Oncology, Indiana University School of Medicine; Founder, CS-Keys
* Christopher Leamon, Ph.D., Vice President of Research, Endocyte - please contact Dr. Leamon directly to request a copy of his slides
* Timothy L. Ratliff, Ph.D. Director Purdue Cancer Center, Purdue University
Translational Science
Moderator: Mark R. Kelley, Ph.D., Indiana University Simon Cancer Center
Panelists:
* Ernest T. Hawk, M.D. MPH, Vice President for Cancer Prevention, Division Head, Cancer Prevention and Population Sciences, University of Texas, M.D. Anderson Cancer Center
* Greg Evans, Ph.D., Program Director, Team Leader, Cancer Biology/Control/Prevention, SBIR Development Center, National Cancer Institute, National Institutes of Health
* Link to NCI SBIR information
Clinical Trials
Moderator: Rudolph M. Navari, M.D., Ph.D. Director, Walther Cancer Center, University of Notre Dame, Assistant Dean and Director, Indiana University School of Medicine South Bend
Panelists:
* Nasser Hanna, M.D., Associate Professor, Department of Medicine, Division of Hematology/Oncology, Indiana University School of Medicine
* Mary Lou Smith, J.D., MBA, Co-Chair of the ECOG Patient Representative Committee, Research Advocacy Network
* Robin Zon, M.D., Director of Research, Memorial Hospital South Bend
Keynote Address: Douglas W. Blayney, M.D., Medical Director, University of Michigan Comprehensive Cancer Center; President-Elect of the American Society of Clinical Oncology
Tailored Therapeutics and Implications for Regulatory Endpoints
Moderator: James Starling, Ph.D., Senior Research Fellow, Cancer Research, Lilly Research Laboratories, Eli Lilly and Co.
Panelists:
* Jerome Yates, M.D. MPH, National Vice President for Research, American Cancer Society, Inc.
* Eric M. Meslin, Ph.D., Director of the Indiana University Center for Bioethics, Associate Dean for Bioethics, Professor of Medicine, Professor of Medical and Molecular Genetics, Indiana University School of Medicine
* Lawrence J. Lesko, Ph.D., FCP, Director, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration
* Silvana Borges, M.D., Medical Officer, Genomics Group, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration
Cancer Care Delivery/Reimbursement
Moderator: Pat Loehrer, M.D., Deputy Director, IU Simon Cancer Center
Panelists:
* Kim Woofter, Practice Administrator, Michiana Hematology-Oncology
* Linda Roberts, VP Managed Care, Clarian Health
* Lisa Harris, M.D., CEO and Medical Director, Wishard Health Services
* Keith Logie, M.D., Central Indiana Cancer Centers, Past President of Indiana Medical Oncology Society and Carrier Advisory Committee Representative
Outcomes and Quality (Metrics)
Moderator: Jo Ann Brooks, Vice President, Quality, Clarian Health
Panelists:
* Douglas W. Blayney, M.D., University of Michigan Comprehensive Cancer Center
* Devonne A. Mullis, M.D., Internal Medicine/Pediatrics, Physician Advisor, Indiana University Hospital, Hospitalist Internal Medicine - Pediatrics
* Linda Battiato, RN, MSN, OCN, Chief Quality Coordinator, IUSCC/Clarian Cancer Programs
|
